Literature DB >> 14742245

Higher vessel densities in retinoblastoma with local invasive growth and metastasis.

Jochen Rössler1, Torsten Dietrich, Helena Pavlakovic, Lothar Schweigerer, Werner Havers, Andreas Schüler, Norbert Bornfeld, Harald Schilling.   

Abstract

In this study, the importance of angiogenesis (the growth of new blood vessels from existing ones) for the growth of retinoblastoma was investigated by a retrospective immunohistochemical analysis. An individual vessel index for each tumor was determined using the endothelial-specific antibody CD 31 for vessel staining. The obtained data were correlated with clinical features, pathohistological characteristics, and the presence of metastasis. In 107 retinoblastomas collected between 1980 and 1990, we found no difference in the vessel densities between uni- and bilateral retinoblastomas (P = 0.41). However, tumors that had invaded the chorioid and/or the optic nerve statistically showed higher vessel densities than tumors without local invasive growth (P = 0.05 and P = 0.024). A tendency of higher vessel densities in retinoblastomas presenting with metastasis at the time of diagnosis was observed (P = 0.11). Based on this observation, we proceeded to examine all retinoblastomas presenting with metastasis at the time of diagnosis. These included patients that were treated between 1968 and 1993. The 18 investigated retinoblastomas had significantly higher vessel densities than all other retinoblastomas presenting without metastasis (P = 0.025). Our data indicate that in retinoblastoma, blood vessels are essential for local and systemic invasive growth. Therefore, an anti-angiogenic therapy could be considered in the multimodal therapy concept for retinoblastomas with invasive growth, both locally and systemically.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14742245      PMCID: PMC1602251          DOI: 10.1016/S0002-9440(10)63129-X

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  23 in total

1.  The epidemiology of ophthalmic malignancies in New York State.

Authors:  M C Mahoney; W S Burnett; A Majerovics; H Tanenbaum
Journal:  Ophthalmology       Date:  1990-09       Impact factor: 12.079

2.  Risk factors for metastases in patients with retinoblastoma.

Authors:  E P Messmer; T Heinrich; W Höpping; E de Sutter; W Havers; W Sauerwein
Journal:  Ophthalmology       Date:  1991-02       Impact factor: 12.079

3.  Induction of angiogenesis during the transition from hyperplasia to neoplasia.

Authors:  J Folkman; K Watson; D Ingber; D Hanahan
Journal:  Nature       Date:  1989-05-04       Impact factor: 49.962

4.  The nature of retinoblastoma. II. Photoreceptor differentiation: an electron microscopic study.

Authors:  M O Ts'o; B S Fine; L E Zimmerman
Journal:  Am J Ophthalmol       Date:  1970-03       Impact factor: 5.258

5.  Metastatic retinoblastoma successfully treated with immunomagnetic purged autologous bone marrow transplantation.

Authors:  R A Saleh; S Gross; W Cassano; A Gee
Journal:  Cancer       Date:  1988-12-01       Impact factor: 6.860

6.  Optic nerve invasion of retinoblastoma. Metastatic potential and clinical risk factors.

Authors:  C L Shields; J A Shields; K Baez; J R Cater; P De Potter
Journal:  Cancer       Date:  1994-02-01       Impact factor: 6.860

7.  Choroidal invasion of retinoblastoma: metastatic potential and clinical risk factors.

Authors:  C L Shields; J A Shields; K A Baez; J Cater; P V De Potter
Journal:  Br J Ophthalmol       Date:  1993-09       Impact factor: 4.638

8.  Retinoblastoma in Great Britain 1969-80: incidence, treatment, and survival.

Authors:  B M Sanders; G J Draper; J E Kingston
Journal:  Br J Ophthalmol       Date:  1988-08       Impact factor: 4.638

9.  Basic fibroblast growth factor is present in cultured human retinoblastoma cells.

Authors:  L Schweigerer; G Neufeld; D Gospodarowicz
Journal:  Invest Ophthalmol Vis Sci       Date:  1987-11       Impact factor: 4.799

10.  Multiple angiogenesis stimulators in a single malignancy: implications for anti-angiogenic tumour therapy.

Authors:  H Pavlakovic; W Havers; L Schweigerer
Journal:  Angiogenesis       Date:  2001       Impact factor: 9.596

View more
  18 in total

1.  Effects of celecoxib in human retinoblastoma cell lines and in a transgenic murine model of retinoblastoma.

Authors:  C T Tong; S A Howard; H R Shah; K R Van Quill; E T Lin; H E Grossniklaus; J M O'Brien
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

2.  Retinoblastoma: value of dynamic contrast-enhanced MR imaging and correlation with tumor angiogenesis.

Authors:  F Rodjan; P de Graaf; P van der Valk; A C Moll; J P A Kuijer; D L Knol; J A Castelijns; P J W Pouwels
Journal:  AJNR Am J Neuroradiol       Date:  2012-05-24       Impact factor: 3.825

3.  Vascular Findings in a Small Retinoblastoma Tumor Using OCT Angiography.

Authors:  Robert J House; S Tammy Hsu; Akshay S Thomas; Avni P Finn; Cynthia A Toth; Miguel A Materin; Lejla Vajzovic
Journal:  Ophthalmol Retina       Date:  2018-09-29

4.  Contrast-enhancement of the anterior eye segment in patients with retinoblastoma: correlation between clinical, MR imaging, and histopathologic findings.

Authors:  P de Graaf; P van der Valk; A C Moll; S M Imhof; A Y N Schouten-van Meeteren; D L Knol; J A Castelijns
Journal:  AJNR Am J Neuroradiol       Date:  2009-10-15       Impact factor: 3.825

5.  Antiangiogenic activity of 2-deoxy-D-glucose.

Authors:  Jaime R Merchan; Krisztina Kovács; Jaclyn W Railsback; Metin Kurtoglu; Yuqi Jing; Yolanda Piña; Ningguo Gao; Timothy G Murray; Mark A Lehrman; Theodore J Lampidis
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

6.  Irresponsiveness of two retinoblastoma cases to conservative therapy correlates with up- regulation of hERG1 channels and of the VEGF-A pathway.

Authors:  Pina Fortunato; Serena Pillozzi; Angela Tamburini; Liliana Pollazzi; Alessandro Franchi; Agostino La Torre; Annarosa Arcangeli
Journal:  BMC Cancer       Date:  2010-09-22       Impact factor: 4.430

7.  Expression of C-kit in retinoblastoma: a potential therapeutic target.

Authors:  Robert J Barry; Letícia R de Moura; Jean-Claude Marshall; Bruno F Fernandes; Maria Eugenia Orellana; Emilia Antecka; Claudia Martins; Miguel N Burnier
Journal:  Br J Ophthalmol       Date:  2007-06-25       Impact factor: 4.638

8.  Basic fibroblast growth factor impact on retinoblastoma progression and survival.

Authors:  Colleen M Cebulla; Maria-Elena Jockovich; Yolanda Piña; Hinda Boutrid; Armando Alegret; Amy Kulak; Abigail S Hackam; Sanjoy K Bhattacharya; William J Feuer; Timothy G Murray
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-07-09       Impact factor: 4.799

9.  The RB tumor suppressor positively regulates transcription of the anti-angiogenic protein NOL7.

Authors:  Tanmayi P Mankame; Mark W Lingen
Journal:  Neoplasia       Date:  2012-12       Impact factor: 5.715

10.  Angiogenesis and vascular network of teratocarcinoma from embryonic stem cell transplant into seminiferous tubules.

Authors:  U Silván; J Arlucea; R Andrade; A Díez-Torre; M Silió; M A Konerding; J Aréchaga
Journal:  Br J Cancer       Date:  2009-06-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.